Open access · US-GOV via ClinicalTrials.gov Clinical trial

Cognitive Function and Prevalence of Amyloid Marker in Frail Older Adults

Authors not listed

University Hospital, Toulouse · 2017

Dysbiosis Human Randomized controlled trial

Abstract

The current study seeks to examine the prevalence of amyloid pathology, among patients referred to the Toulouse Geriatric Frailty Clinic presenting objective memory impairment. We also aim to fully characterize the clinical progression of frail cognitively impaired patients presenting AD (Alzheimer Disease) pathology vs those who also present a cognitive impairment but do not have AD pathology.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-07-02 MST

Cite this

APA

Anonymous. (2017). Cognitive Function and Prevalence of Amyloid Marker in Frail Older Adults. <em>University Hospital, Toulouse</em>. https://clinicaltrials.gov/study/NCT03129269

Vancouver

Anonymous. Cognitive Function and Prevalence of Amyloid Marker in Frail Older Adults. University Hospital, Toulouse. 2017.

BibTeX

@misc{anon2017Cognit, title = {Cognitive Function and Prevalence of Amyloid Marker in Frail Older Adults}, author = {Anonymous}, journal = {University Hospital, Toulouse}, year = {2017}, }